The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19
COVRehab
1 other identifier
interventional
48
1 country
1
Brief Summary
Patients who receive intensive care are known to be at high risk for physical, psychological, and cognitive impairments, a constellation known as PICS. COVID-19 patients are expected to have high chances of suffering from PICS (PICS-COV) as they frequently require several weeks of intensive care and traditional PICS preventive measures are virtually impossible due to infection control precautions, prone positioning, and deprivation of social contact. To prevent PICS after ICU discharge in COVID-19 patients, physical therapy is recommended. From recent but limited experience it appears that even patients with COVID-19 who have not been admitted to the ICU can suffer from impairments in the same domains and sometimes to a similar degree of severity. Also for these patient group rehabilitation seems warranted. Yet, the resources needed to provide rehabilitation treatment to COVID-19 patients are inadequate because healthcare systems faced a shortage of high-quality treatment for these impairments already before the COVID-19 crisis emerged. Virtual Reality (VR) provides potential to healthcare practitioners to administer fast, temporary, and tailor-made rehabilitation services at a distance, and offers a solution to address the impending surge of demand for rehabilitation after COVID-19 infection. VR consists of a head mounted display (HMD) that can bring the user by computer-generated visuals into an immersive, realistic multi-sensory environment. Current VR technology is accessible, easy in use for a large audience, and safe in use. There already exist multiple VR applications for providing physical, psychological, and cognitive rehabilitation. These applications have been brought together in a VR suite for rehabilitation after COVID-19. Patients visiting a physiotherapist for rehabilitation from COVID-19 will be asked to participate in this study. They receive a VR HMD for training purposes. This study aims to understand the usability, feasibility, and tolerability of VR for rehabilitation after COVID-19, and to pilot the effectiveness of VR improving the physical ability, mental and cognitive status of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedFirst Posted
Study publicly available on registry
August 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2021
CompletedApril 6, 2021
June 1, 2020
6 months
July 3, 2020
April 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Semi-structured interview with 15 patients on their experiences of VR for rehabilitation from COVID-19.
At the end of the study, 15 patients will be interviewed about their experiences using VR for rehabilitation from COVID-19. The interview will be semi-structured, including questions on usability, tolerability and efficacy of VR according to the patients. The interviews will be recorded, written out and coded by means of grounded theory analysis in Atlas.ti. Themes and subthemes will be constructed.
Day 42
Use of VR
By means of digital tracking in the VR goggles, we aim to understand what games are used most often by the participants.
Day 42
Semi-structured interviews with physiotherapists on their experiences of VR for rehabilitation from COVID-19.
At the end of the study, 10 physiotherapists will be interviewed about their experiences using VR for rehabilitation from COVID-19. The interview will be semi-structured, including questions on usability, tolerability and efficacy of VR according to the physiotherapists. The interviews will be recorded, written out and coded by means of grounded theory analysis in Atlas.ti. Themes and subthemes will be constructed.
Day 42
Secondary Outcomes (10)
Change in baseline performance test (guidelines KNGF) - Patient specific complaints.
Day 0, day 42
Change in baseline performance test (guidelines KNGF) - 6 minute walk test
Day 0, Day 42
Change in baseline performance test (guidelines KNGF) - one-repetition maximum test
Day 0, Day 42
Change in baseline performance test (guidelines KNGF) - 30 sec sit to stand
Day 0, Day 42
Change in baseline performance test (guidelines KNGF) - Borgscale for fatigue
Day 0, Day 42
- +5 more secondary outcomes
Other Outcomes (1)
Patient characteristics related to use of VR
Day 0
Study Arms (1)
Intervention group
EXPERIMENTALParticipants will receive Virtual Reality as an add-on to standard physiotherapy after COVID-19.
Interventions
Participants will use a Virtual Reality headset with a range of applications applicable for rehabilitation after COVID-19. Applications target physical, psychological, and cognitive rehabilitation. VR headset will be used for six weeks first at the physiotherapist's practice, and when possible, at home.
Eligibility Criteria
You may qualify if:
- Patient has had COVID-19.
- Patient has an indication for physical therapy in the context of rehabilitation after COVID-19.
- Patient is willing and able to comply with the study protocol.
- Patient is at least 16 years old on the day the informed consent form will be signed.
- Patient can read and understand the Dutch language.
You may not qualify if:
- The patient is participating in another study interfering with this study.
- Patient has difficulties to handle virtual reality:
- Patient suffers from delirium or acute confusional state.
- Patient has (a history of) dementia, seizure, or epilepsy.
- Patient has severe hearing/visual impairment not corrected.
- The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
- Patient has a high risk of contamination with a therapy resistant micro-organism e.g. MRSA.
- Patients suffers from severe anxiety or depression (HADS≥16).
- Red flags (see Appendix 1).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Radboud university medical center
Nijmegen, Gelderland, 6525 GA, Netherlands
Related Publications (1)
Groenveld T, Achttien R, Smits M, de Vries M, van Heerde R, Staal B, van Goor H; COVID Rehab Group. Feasibility of Virtual Reality Exercises at Home for Post-COVID-19 Condition: Cohort Study. JMIR Rehabil Assist Technol. 2022 Aug 15;9(3):e36836. doi: 10.2196/36836.
PMID: 35858254DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harry van Goor, MD, PhD
Radboud University Medical Center
- PRINCIPAL INVESTIGATOR
Bart Staal, PT, PhD
Radboud University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2020
First Posted
August 10, 2020
Study Start
August 1, 2020
Primary Completion
February 1, 2021
Study Completion
March 31, 2021
Last Updated
April 6, 2021
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
Only upon asking.